185 related articles for article (PubMed ID: 19246639)
1. Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.
Kosugi T; Heinig M; Nakayama T; Connor T; Yuzawa Y; Li Q; Hauswirth WW; Grant MB; Croker BP; Campbell-Thompson M; Zhang L; Atkinson MA; Segal MS; Nakagawa T
Am J Pathol; 2009 Apr; 174(4):1221-9. PubMed ID: 19246639
[TBL] [Abstract][Full Text] [Related]
2. eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.
Kosugi T; Heinig M; Nakayama T; Matsuo S; Nakagawa T
Am J Pathol; 2010 Feb; 176(2):619-29. PubMed ID: 20042665
[TBL] [Abstract][Full Text] [Related]
3. Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse.
Tanabe K; Lanaspa MA; Kitagawa W; Rivard CJ; Miyazaki M; Klawitter J; Schreiner GF; Saleem MA; Mathieson PW; Makino H; Johnson RJ; Nakagawa T
Am J Physiol Renal Physiol; 2012 May; 302(9):F1151-60. PubMed ID: 22338086
[TBL] [Abstract][Full Text] [Related]
4. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice.
Zhang MZ; Wang S; Yang S; Yang H; Fan X; Takahashi T; Harris RC
Am J Physiol Renal Physiol; 2012 Feb; 302(4):F433-8. PubMed ID: 22114203
[TBL] [Abstract][Full Text] [Related]
5. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
Nakagawa T; Sato W; Glushakova O; Heinig M; Clarke T; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Johnson RJ; Croker B
J Am Soc Nephrol; 2007 Feb; 18(2):539-50. PubMed ID: 17202420
[TBL] [Abstract][Full Text] [Related]
6. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
Gangadharan Komala M; Gross S; Zaky A; Pollock C; Panchapakesan U
Nephrology (Carlton); 2016 May; 21(5):423-31. PubMed ID: 26375854
[TBL] [Abstract][Full Text] [Related]
7. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism.
Advani A; Huang Q; Thai K; Advani SL; White KE; Kelly DJ; Yuen DA; Connelly KA; Marsden PA; Gilbert RE
Am J Pathol; 2011 May; 178(5):2205-14. PubMed ID: 21514434
[TBL] [Abstract][Full Text] [Related]
8. Chronic hypoxia exacerbates diabetic glomerulosclerosis through mesangiolysis and podocyte injury in db/db mice.
Takahashi N; Yoshida H; Kimura H; Kamiyama K; Kurose T; Sugimoto H; Imura T; Yokoi S; Mikami D; Kasuno K; Kurosawa H; Hirayama Y; Naiki H; Hara M; Iwano M
Nephrol Dial Transplant; 2020 Oct; 35(10):1678-1688. PubMed ID: 32596728
[TBL] [Abstract][Full Text] [Related]
9. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
10. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
[TBL] [Abstract][Full Text] [Related]
11. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
12. Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.
Yang YY; Shi LX; Li JH; Yao LY; Xiang DX
Mol Med Rep; 2019 Mar; 19(3):2245-2253. PubMed ID: 30664213
[TBL] [Abstract][Full Text] [Related]
13. The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy.
Sato W; Kosugi T; Zhang L; Roncal CA; Heinig M; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Grant MB; Croker BP; Nakagawa T
Lab Invest; 2008 Sep; 88(9):949-61. PubMed ID: 18607348
[TBL] [Abstract][Full Text] [Related]
14. Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol.
DeRubertis FR; Craven PA; Melhem MF
Metabolism; 2007 Sep; 56(9):1256-64. PubMed ID: 17697870
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.
Kanetsuna Y; Takahashi K; Nagata M; Gannon MA; Breyer MD; Harris RC; Takahashi T
Am J Pathol; 2007 May; 170(5):1473-84. PubMed ID: 17456755
[TBL] [Abstract][Full Text] [Related]
16. Comparison of diabetic nephropathy between male and female eNOS
Ma Y; Li W; Yazdizadeh Shotorbani P; Dubansky BH; Huang L; Chaudhari S; Wu P; Wang LA; Ryou MG; Zhou Z; Ma R
Am J Physiol Renal Physiol; 2019 May; 316(5):F889-F897. PubMed ID: 30810354
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.
Gangadharan Komala M; Gross S; Mudaliar H; Huang C; Pegg K; Mather A; Shen S; Pollock CA; Panchapakesan U
PLoS One; 2014; 9(11):e108994. PubMed ID: 25369239
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
Daniel C; Schaub K; Amann K; Lawler J; Hugo C
Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
[TBL] [Abstract][Full Text] [Related]
19. eNOS deficiency predisposes podocytes to injury in diabetes.
Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
